Since these phosphatases are negative regulators of ERK1/2 activation, such downregulation of negative regulators of ERK1/2 may be one of factors in the activation of ERK1/2 in adenocarcinomas, although examples induced by NNK at 52 weeks have not been analyzed so far. Here, MAPK3 is linked to adenocarcinoma.